Pilaralisib inhibits the replication of enteroviruses by targeting the PI3K/AKT signaling pathway
Abstract Enterovirus 71 (EV71) is a significant pathogen responsible for hand, foot, and mouth disease (HFMD), which poses a substantial public health concern, particularly in the Asia-Pacific region. The virus is transmitted primarily through the fecal-oral route and via respiratory droplets, enter...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Virology Journal |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12985-025-02881-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849333759246073856 |
|---|---|
| author | Jie Zhou Yanping Wang Guangyan Zhu Mingzhe Yan Zhengnan Li Lin Li Jingwen Kuang Wenyuan Zhang Chaolin Huang Fuli Ren Qingyu Yang |
| author_facet | Jie Zhou Yanping Wang Guangyan Zhu Mingzhe Yan Zhengnan Li Lin Li Jingwen Kuang Wenyuan Zhang Chaolin Huang Fuli Ren Qingyu Yang |
| author_sort | Jie Zhou |
| collection | DOAJ |
| description | Abstract Enterovirus 71 (EV71) is a significant pathogen responsible for hand, foot, and mouth disease (HFMD), which poses a substantial public health concern, particularly in the Asia-Pacific region. The virus is transmitted primarily through the fecal-oral route and via respiratory droplets, entering the host via the gastrointestinal tract where it replicates before spreading to the central nervous system. The virus predominantly affects children under five years of age, often resulting in severe neurological complications, including aseptic meningitis, acute flaccid paralysis, and, in some cases, death. Despite the development of vaccines, global control of EV71 remains challenging due to its high genetic variability. The PI3K/Akt signaling pathway plays a critical role in regulating various cellular processes, such as cell survival, proliferation, and differentiation. This pathway is frequently exploited by viruses to facilitate infection and replication. Consequently, therapeutic interventions that target the PI3K/Akt pathway emerge as a promising strategy to combat viral infections, including EV71. Notably, the PI3K inhibitor Pilaralisib has demonstrated efficacy in reducing EV71-induced mortality by 50–80% in animal models. However, its low cellular safety profile poses limitations to its therapeutic potential. This study sought to investigate the role of the PI3K/Akt pathway in EV71 infection and the potential of its inhibitors as a therapeutic strategy. We examined the effects of PI3K inhibition on EV71 replication both in vitro and in vivo, exploring the underlying mechanisms. Our findings suggest that the PI3K/Akt signaling pathway is involved in the replication of EV71 and that its inhibition could offer a promising approach to preventing or alleviating the severity of HFMD. |
| format | Article |
| id | doaj-art-2380f78b10e147dbb86b03f2d2806e7b |
| institution | Kabale University |
| issn | 1743-422X |
| language | English |
| publishDate | 2025-07-01 |
| publisher | BMC |
| record_format | Article |
| series | Virology Journal |
| spelling | doaj-art-2380f78b10e147dbb86b03f2d2806e7b2025-08-20T03:45:45ZengBMCVirology Journal1743-422X2025-07-0122111110.1186/s12985-025-02881-wPilaralisib inhibits the replication of enteroviruses by targeting the PI3K/AKT signaling pathwayJie Zhou0Yanping Wang1Guangyan Zhu2Mingzhe Yan3Zhengnan Li4Lin Li5Jingwen Kuang6Wenyuan Zhang7Chaolin Huang8Fuli Ren9Qingyu Yang10Wuhan Jinyintan Hospital, Tongji Medical College of Huazhong, University of Science and TechnologyObstetrics and Gynecology Department, HuBei Provincial Hospital of TCMDepartment of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyWuhan Jinyintan Hospital, Tongji Medical College of Huazhong, University of Science and TechnologyWuhan Jinyintan Hospital, Tongji Medical College of Huazhong, University of Science and TechnologyWuhan Jinyintan Hospital, Tongji Medical College of Huazhong, University of Science and TechnologyDivision of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of ChinaWuhan Jinyintan Hospital, Tongji Medical College of Huazhong, University of Science and TechnologyWuhan Jinyintan Hospital, Tongji Medical College of Huazhong, University of Science and TechnologyWuhan Jinyintan Hospital, Tongji Medical College of Huazhong, University of Science and TechnologyWuhan Jinyintan Hospital, Tongji Medical College of Huazhong, University of Science and TechnologyAbstract Enterovirus 71 (EV71) is a significant pathogen responsible for hand, foot, and mouth disease (HFMD), which poses a substantial public health concern, particularly in the Asia-Pacific region. The virus is transmitted primarily through the fecal-oral route and via respiratory droplets, entering the host via the gastrointestinal tract where it replicates before spreading to the central nervous system. The virus predominantly affects children under five years of age, often resulting in severe neurological complications, including aseptic meningitis, acute flaccid paralysis, and, in some cases, death. Despite the development of vaccines, global control of EV71 remains challenging due to its high genetic variability. The PI3K/Akt signaling pathway plays a critical role in regulating various cellular processes, such as cell survival, proliferation, and differentiation. This pathway is frequently exploited by viruses to facilitate infection and replication. Consequently, therapeutic interventions that target the PI3K/Akt pathway emerge as a promising strategy to combat viral infections, including EV71. Notably, the PI3K inhibitor Pilaralisib has demonstrated efficacy in reducing EV71-induced mortality by 50–80% in animal models. However, its low cellular safety profile poses limitations to its therapeutic potential. This study sought to investigate the role of the PI3K/Akt pathway in EV71 infection and the potential of its inhibitors as a therapeutic strategy. We examined the effects of PI3K inhibition on EV71 replication both in vitro and in vivo, exploring the underlying mechanisms. Our findings suggest that the PI3K/Akt signaling pathway is involved in the replication of EV71 and that its inhibition could offer a promising approach to preventing or alleviating the severity of HFMD.https://doi.org/10.1186/s12985-025-02881-wEV71Antiviral agentsPI3K/AKT signaling pathwayVirus replicationHFMD |
| spellingShingle | Jie Zhou Yanping Wang Guangyan Zhu Mingzhe Yan Zhengnan Li Lin Li Jingwen Kuang Wenyuan Zhang Chaolin Huang Fuli Ren Qingyu Yang Pilaralisib inhibits the replication of enteroviruses by targeting the PI3K/AKT signaling pathway Virology Journal EV71 Antiviral agents PI3K/AKT signaling pathway Virus replication HFMD |
| title | Pilaralisib inhibits the replication of enteroviruses by targeting the PI3K/AKT signaling pathway |
| title_full | Pilaralisib inhibits the replication of enteroviruses by targeting the PI3K/AKT signaling pathway |
| title_fullStr | Pilaralisib inhibits the replication of enteroviruses by targeting the PI3K/AKT signaling pathway |
| title_full_unstemmed | Pilaralisib inhibits the replication of enteroviruses by targeting the PI3K/AKT signaling pathway |
| title_short | Pilaralisib inhibits the replication of enteroviruses by targeting the PI3K/AKT signaling pathway |
| title_sort | pilaralisib inhibits the replication of enteroviruses by targeting the pi3k akt signaling pathway |
| topic | EV71 Antiviral agents PI3K/AKT signaling pathway Virus replication HFMD |
| url | https://doi.org/10.1186/s12985-025-02881-w |
| work_keys_str_mv | AT jiezhou pilaralisibinhibitsthereplicationofenterovirusesbytargetingthepi3kaktsignalingpathway AT yanpingwang pilaralisibinhibitsthereplicationofenterovirusesbytargetingthepi3kaktsignalingpathway AT guangyanzhu pilaralisibinhibitsthereplicationofenterovirusesbytargetingthepi3kaktsignalingpathway AT mingzheyan pilaralisibinhibitsthereplicationofenterovirusesbytargetingthepi3kaktsignalingpathway AT zhengnanli pilaralisibinhibitsthereplicationofenterovirusesbytargetingthepi3kaktsignalingpathway AT linli pilaralisibinhibitsthereplicationofenterovirusesbytargetingthepi3kaktsignalingpathway AT jingwenkuang pilaralisibinhibitsthereplicationofenterovirusesbytargetingthepi3kaktsignalingpathway AT wenyuanzhang pilaralisibinhibitsthereplicationofenterovirusesbytargetingthepi3kaktsignalingpathway AT chaolinhuang pilaralisibinhibitsthereplicationofenterovirusesbytargetingthepi3kaktsignalingpathway AT fuliren pilaralisibinhibitsthereplicationofenterovirusesbytargetingthepi3kaktsignalingpathway AT qingyuyang pilaralisibinhibitsthereplicationofenterovirusesbytargetingthepi3kaktsignalingpathway |